Unichem Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹575.12 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.35 per cent from ₹521.17 crore. This corresponds to a year-on-year *(YoY) decline of 2.05 per cent.
Operating Profit
Operating Profit stands at ₹35.32 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.13 per cent from ₹44.78 crore. This corresponds to a year-on-year *(YoY) decline of 57.80 per cent.
PBDT
PBDT stands at ₹49.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 84.79 per cent from ₹324.68 crore. This corresponds to a year-on-year *(YoY) decline of 43.54 per cent.
Profit Before Tax
Profit Before Tax stands at ₹18.79 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 93.60 per cent from ₹293.43 crore. This corresponds to a year-on-year *(YoY) decline of 67.49 per cent.
Net Profit
Net Profit stands at ₹10.91 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 95.87 per cent from ₹264.29 crore. This represents a 79.40 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Unichem Laboratories Ltd News
Unichem Laboratories Ltd Earnings
- YOY
- QOQ
Unichem Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Unichem Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Unichem Laboratories Ltd Financial Reports
Unichem Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Unichem Labs. | -1.49% | 0.60% | 17.10% | 41.87% | 44.46% | -15.64% |
| Novartis India | -2.76% | -6.71% | 10.00% | 53.27% | 107.11% | 59.01% |
| Guj. Themis Bio. | -1.25% | 1.35% | -7.22% | -5.15% | 14.59% | -8.67% |
| Gufic BioScience | -1.43% | -1.81% | -1.69% | 31.84% | 24.02% | -1.29% |
| Aarti Drugs | -1.13% | -1.02% | 9.37% | 9.26% | 8.98% | -24.22% |
| SMS Pharma. | -1.77% | -1.20% | 0.70% | -6.52% | 23.88% | 61.68% |
| Advanced Enzyme | -0.82% | 0.58% | -2.46% | -6.62% | 5.48% | -9.66% |
Company Info
Company Information
Chairman(Non Exe)&Dir(Non-Ind) : Prakash A Mody
Managing Director & CEO : Pabitra Bhattacharya
Non-Exec & Non-Independent Dir : Pranay Godha
Independent Non Exe. Director : Anand T Kusre
Independent Non Exe. Director : Arun Todarwal
Independent Non Exe. Director : Swati Patankar
HEAD - LEGAL / CS / CHIEF COMPLIANCE OFFICER : Pradeep Bhandari